US Bancorp’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.3K Buy
+1,350
New +$12.4K ﹤0.01% 3388
2025
Q4
– Sell
-1,000
Closed -$6.86K – 4188
2025
Q3
$6.86K Buy
+1,000
New +$8.11K ﹤0.01% 3437

Other funds holding SGMT

US Bancorp's SGMT Position: Q3 2026 in Review

US Bancorp opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 1,350 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #3388 among its holdings. This is a return to the name: US Bancorp previously reported a position in SGMT as recently as Q3 2025.

US Bancorp first reported a position in SGMT in Q3 2025 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • US Bancorp held 1,350 shares of Sagimet Biosciences worth $13.3K as of Q3 2026.
  • Sagimet Biosciences was a new US Bancorp position in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3388 holding.
  • US Bancorp first reported a position in Sagimet Biosciences in Q3 2025 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.